Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 3
Submit an article Journal homepage
256
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Economical aspect of biological therapy in inflammatory conditions in Hungary

Judit LakiDepartment of Medical Expertise, Clinical Auditing and Analysis, National Health Insurance Fund Administration, Váci út 73./A, 1139 Budapest, Hungary+36 1 288 5213; +36 1 288 5340; [email protected]
, MD PhD,
Gabriella MónokDepartment of Medical Expertise, Clinical Auditing and Analysis, National Health Insurance Fund Administration, Váci út 73./A, 1139 Budapest, Hungary+36 1 288 5213; +36 1 288 5340; [email protected]
, BSc,
Mihály PálosiDepartment of Medical Expertise, Clinical Auditing and Analysis, National Health Insurance Fund Administration, Váci út 73./A, 1139 Budapest, Hungary+36 1 288 5213; +36 1 288 5340; [email protected]
, MD &
József Zs GajdácsiDepartment of Medical Expertise, Clinical Auditing and Analysis, National Health Insurance Fund Administration, Váci út 73./A, 1139 Budapest, Hungary+36 1 288 5213; +36 1 288 5340; [email protected]
, MD
Pages 327-337 | Published online: 20 Nov 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Valentin Brodszky, Anikó Bíró, Zoltán Szekanecz, Boglárka Soós, Petra Baji, Fanni Rencz, László Tóthfalusi, László Gulácsi & Márta Péntek. (2017) Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data. ClinicoEconomics and Outcomes Research 9, pages 139-147.
Read now

Articles from other publishers (7)

András Inotai, Dominik Tomek, Maciej Niewada, László Lorenzovici, Martin Kolek, Jakub Weber, Anne-Katrin Kurrat, Emese Virág Kiss & Zoltán Kaló. (2020) Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries. Frontiers in Pharmacology 11.
Crossref
F. Rencz, L. Kemény, J.Z. Gajdácsi, W. Owczarek, P. Arenberger, G.S. Tiplica, A. Stanimirović, M. Niewada, G. Petrova, L.T. Marinov, M. Péntek, V. Brodszky & L. Gulácsi. (2015) Use of biologics for psoriasis in Central and Eastern European countries. Journal of the European Academy of Dermatology and Venereology 29:11, pages 2222-2230.
Crossref
Ferenc Oberfrank. (2014) The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary. Value in Health Regional Issues 4, pages 6-7.
Crossref
L. Gulácsi & M. Péntek. (2014) HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain. The European Journal of Health Economics 15:7, pages 675-680.
Crossref
Orsolya Balogh, Valentin Brodszky, L?szl? Gul?csi, Emese Her?di, Krisztina Hersz?nyi, Hajnalka J?kai, Sarolta K?rp?ti, Petra Baji, ?va Remenyik, Andrea Szegedi & P?ter Holl?. (2014) Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres. The European Journal of Health Economics 15:S1, pages 101-109.
Crossref
Valentin Brodszky, Petra Baji, Orsolya Balogh & M?rta P?ntek. (2014) Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries. The European Journal of Health Economics 15:S1, pages 65-71.
Crossref
Márta Péntek, Gyula Poór, Piotr Wiland, Martina Olejárová, Marek Brzosko, Catalin Codreanu, Nóra Brodszky & László Gulácsi. (2014) Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries. The European Journal of Health Economics 15:S1, pages 35-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.